-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C8wW4h/aI+dDAQpUzISHO35FldzZAsRqxnNE+1PVD0cLd9pSHgEKuy2q4B6N5MJp 1FGRBNnHhhmpk+es7zS1zQ== 0000950123-06-004206.txt : 20060404 0000950123-06-004206.hdr.sgml : 20060404 20060404161320 ACCESSION NUMBER: 0000950123-06-004206 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUATRX PHARMACEUTICALS CO CENTRAL INDEX KEY: 0001166029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-51893 FILM NUMBER: 06738252 BUSINESS ADDRESS: STREET 1: 777 EAST EISENHOWER PARKWAY STREET 2: SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734 913 9900 8-A12G 1 y19410e8va12g.htm 8-A12G 8-A12G
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
QuatRx Pharmaceuticals Company
(Exact name of registrant as specified in its charter)
     
Delaware   38-3566182
     
     
(State of incorporation or organization)   (I.R.S. Employer Identification No.)
     
777 East Eisenhower Parkway, Suite 100   48108
     
Ann Arbor, MI    
     
     
(Address of principal executive offices)   (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
     
Title of each class   Name of each exchange on
to be so registered   which each class is to be registered
     
Not Applicable   Not Applicable
     
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. o
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. þ
Securities Act registration statement file number to which this form relates: 333-131537
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.01 per share
 
(Title of Class)
 
 

 

TABLE OF CONTENTS

Item 1. Description of Registrant’s Securities to be Registered.
Item 2. Exhibits.
SIGNATURE

Table of Contents

INFORMATION REQUIRED IN REGISTRATION STATEMENT
     Item 1. Description of Registrant’s Securities to be Registered.
     Incorporated herein by reference to the information set forth under the heading “Description of Capital Stock” contained in the Registrant’s Registration Statement on Form S-1 under the Securities Act of 1933, as amended (the “Registration Statement”) (Registration No. 333-131537).
     Item 2. Exhibits.
     The following exhibits are filed as part of the Registration Statement.
     
EXHIBIT    
NUMBER   DESCRIPTION
 
    
3.1(1)
  Eighth Amended and Restated Certificate of Incorporation, as currently in effect
 
    
3.2(1)
  Certificate of Amendment to Certificate of Incorporation, as currently in effect
 
    
3.3(1)
  Second Certificate of Amendment to Certificate of Incorporation, as currently in effect
 
    
3.4(1)
  Bylaws, as currently in effect
 
    
3.5(1)
  Form of Amended Restated Certificate of Incorporation (to be filed in connection with the closing of this offering pursuant to the Registration Statement)
 
    
3.6(1)
  Form of Amended and Restated Bylaws (to be effective upon the closing of this offering pursuant to the Registration Statement)
 
    
4.1(1)
  Fourth Amended and Restated Investor Rights Agreement, entered into as of November 22, 2004, by and among QuatRx Pharmaceuticals Company and certain investors named therein
 
    
4.2(1)
  Amendment to Fourth Amended and Restated Investor Rights Agreement, entered into as of May 25, 2005, by and among QuatRx Pharmaceuticals Company and certain investors named therein
 
    
4.3(1)
  Specimen Common Stock Certificate
(1)   Filed as an exhibit to the Registration Statement and incorporated herein by reference.

2

Table of Contents

SIGNATURE
     Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
             
Date:   April 3, 2006   QuatRx Pharmaceuticals Company    
         
    (Registrant)    
 
            
 
  By:   /s/ Gary Onn    
 
           
 
  Name:   Gary Onn    
 
  Title:   Chief Financial Officer    

3

-----END PRIVACY-ENHANCED MESSAGE-----